nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—HTR1B—artery—uterine cancer	0.0111	0.0618	CbGeAlD
Cabergoline—HTR1D—artery—uterine cancer	0.0107	0.0598	CbGeAlD
Cabergoline—HTR7—artery—uterine cancer	0.00852	0.0477	CbGeAlD
Cabergoline—ADRA1D—epithelium—uterine cancer	0.00543	0.0304	CbGeAlD
Cabergoline—HTR2A—artery—uterine cancer	0.00532	0.0297	CbGeAlD
Cabergoline—ADRA1B—renal system—uterine cancer	0.00515	0.0288	CbGeAlD
Cabergoline—DRD5—female reproductive system—uterine cancer	0.00503	0.0281	CbGeAlD
Cabergoline—HTR2B—myometrium—uterine cancer	0.00481	0.0269	CbGeAlD
Cabergoline—DRD5—female gonad—uterine cancer	0.00458	0.0256	CbGeAlD
Cabergoline—ADRA1D—female reproductive system—uterine cancer	0.00403	0.0226	CbGeAlD
Cabergoline—ADRA2C—myometrium—uterine cancer	0.00379	0.0212	CbGeAlD
Cabergoline—HTR2B—uterine cervix—uterine cancer	0.00374	0.0209	CbGeAlD
Cabergoline—HTR2B—smooth muscle tissue—uterine cancer	0.00364	0.0203	CbGeAlD
Cabergoline—HTR2B—decidua—uterine cancer	0.00357	0.0199	CbGeAlD
Cabergoline—HTR2B—endometrium—uterine cancer	0.00338	0.0189	CbGeAlD
Cabergoline—HTR7—epithelium—uterine cancer	0.00323	0.0181	CbGeAlD
Cabergoline—HTR1A—renal system—uterine cancer	0.00314	0.0175	CbGeAlD
Cabergoline—HTR2B—uterus—uterine cancer	0.00312	0.0174	CbGeAlD
Cabergoline—ADRA1A—epithelium—uterine cancer	0.00312	0.0174	CbGeAlD
Cabergoline—HTR7—smooth muscle tissue—uterine cancer	0.00311	0.0174	CbGeAlD
Cabergoline—HTR1B—female reproductive system—uterine cancer	0.00311	0.0174	CbGeAlD
Cabergoline—ADRA2A—myometrium—uterine cancer	0.00302	0.0169	CbGeAlD
Cabergoline—HTR1D—female reproductive system—uterine cancer	0.00301	0.0169	CbGeAlD
Cabergoline—HTR7—renal system—uterine cancer	0.003	0.0168	CbGeAlD
Cabergoline—HTR2C—female reproductive system—uterine cancer	0.00298	0.0167	CbGeAlD
Cabergoline—ADRA2C—uterine cervix—uterine cancer	0.00295	0.0165	CbGeAlD
Cabergoline—ADRB1—female reproductive system—uterine cancer	0.00293	0.0164	CbGeAlD
Cabergoline—ADRA1A—renal system—uterine cancer	0.00289	0.0162	CbGeAlD
Cabergoline—ADRA2C—decidua—uterine cancer	0.00281	0.0157	CbGeAlD
Cabergoline—HTR2B—female reproductive system—uterine cancer	0.0028	0.0157	CbGeAlD
Cabergoline—ADRA2C—renal system—uterine cancer	0.00276	0.0154	CbGeAlD
Cabergoline—ADRA2C—endometrium—uterine cancer	0.00266	0.0149	CbGeAlD
Cabergoline—ADRA2C—mammalian vulva—uterine cancer	0.00258	0.0144	CbGeAlD
Cabergoline—HTR2B—vagina—uterine cancer	0.00254	0.0142	CbGeAlD
Cabergoline—ADRA2C—uterus—uterine cancer	0.00245	0.0137	CbGeAlD
Cabergoline—HTR7—female reproductive system—uterine cancer	0.0024	0.0134	CbGeAlD
Cabergoline—ADRA2A—uterine cervix—uterine cancer	0.00235	0.0131	CbGeAlD
Cabergoline—ADRA2A—decidua—uterine cancer	0.00224	0.0125	CbGeAlD
Cabergoline—ADRA2A—endometrium—uterine cancer	0.00213	0.0119	CbGeAlD
Cabergoline—ADRA2A—mammalian vulva—uterine cancer	0.00206	0.0115	CbGeAlD
Cabergoline—HTR2A—epithelium—uterine cancer	0.00202	0.0113	CbGeAlD
Cabergoline—ADRA2C—female gonad—uterine cancer	0.00201	0.0112	CbGeAlD
Cabergoline—ADRA2C—vagina—uterine cancer	0.002	0.0112	CbGeAlD
Cabergoline—ADRA2A—uterus—uterine cancer	0.00196	0.011	CbGeAlD
Cabergoline—HTR2A—smooth muscle tissue—uterine cancer	0.00194	0.0109	CbGeAlD
Cabergoline—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.00236	CcSEcCtD
Cabergoline—Neoplasm malignant—Doxorubicin—uterine cancer	0.00193	0.00234	CcSEcCtD
Cabergoline—Decreased appetite—Progesterone—uterine cancer	0.00192	0.00234	CcSEcCtD
Cabergoline—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00191	0.00232	CcSEcCtD
Cabergoline—Fatigue—Progesterone—uterine cancer	0.00191	0.00232	CcSEcCtD
Cabergoline—Dyskinesia—Epirubicin—uterine cancer	0.00189	0.0023	CcSEcCtD
Cabergoline—Constipation—Progesterone—uterine cancer	0.00189	0.0023	CcSEcCtD
Cabergoline—Pain—Progesterone—uterine cancer	0.00189	0.0023	CcSEcCtD
Cabergoline—Breast pain—Doxorubicin—uterine cancer	0.00188	0.00229	CcSEcCtD
Cabergoline—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00187	0.00228	CcSEcCtD
Cabergoline—HTR2A—renal system—uterine cancer	0.00187	0.0105	CbGeAlD
Cabergoline—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00182	0.00222	CcSEcCtD
Cabergoline—Feeling abnormal—Progesterone—uterine cancer	0.00182	0.00222	CcSEcCtD
Cabergoline—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.00221	CcSEcCtD
Cabergoline—Arthropathy—Doxorubicin—uterine cancer	0.00181	0.0022	CcSEcCtD
Cabergoline—Gastrointestinal pain—Progesterone—uterine cancer	0.00181	0.0022	CcSEcCtD
Cabergoline—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00219	CcSEcCtD
Cabergoline—Musculoskeletal pain—Epirubicin—uterine cancer	0.0018	0.00219	CcSEcCtD
Cabergoline—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00217	CcSEcCtD
Cabergoline—Pneumonia—Etoposide—uterine cancer	0.00178	0.00217	CcSEcCtD
Cabergoline—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00178	0.00217	CcSEcCtD
Cabergoline—Ill-defined disorder—Dactinomycin—uterine cancer	0.00178	0.00216	CcSEcCtD
Cabergoline—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00215	CcSEcCtD
Cabergoline—ADRA2A—female reproductive system—uterine cancer	0.00176	0.00985	CbGeAlD
Cabergoline—Dyskinesia—Doxorubicin—uterine cancer	0.00175	0.00213	CcSEcCtD
Cabergoline—Abdominal pain—Progesterone—uterine cancer	0.00175	0.00213	CcSEcCtD
Cabergoline—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00174	0.00212	CcSEcCtD
Cabergoline—CYP3A4—renal system—uterine cancer	0.00173	0.00968	CbGeAlD
Cabergoline—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.0021	CcSEcCtD
Cabergoline—Malaise—Dactinomycin—uterine cancer	0.00173	0.0021	CcSEcCtD
Cabergoline—Influenza like illness—Epirubicin—uterine cancer	0.00173	0.0021	CcSEcCtD
Cabergoline—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00209	CcSEcCtD
Cabergoline—Musculoskeletal pain—Doxorubicin—uterine cancer	0.00166	0.00203	CcSEcCtD
Cabergoline—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00201	CcSEcCtD
Cabergoline—HTR2B—lymph node—uterine cancer	0.00164	0.00917	CbGeAlD
Cabergoline—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.00199	CcSEcCtD
Cabergoline—Cramps of lower extremities—Epirubicin—uterine cancer	0.00163	0.00199	CcSEcCtD
Cabergoline—Hypersensitivity—Progesterone—uterine cancer	0.00163	0.00198	CcSEcCtD
Cabergoline—Discomfort—Dactinomycin—uterine cancer	0.00161	0.00196	CcSEcCtD
Cabergoline—ADRA2A—female gonad—uterine cancer	0.0016	0.00896	CbGeAlD
Cabergoline—Influenza like illness—Doxorubicin—uterine cancer	0.0016	0.00194	CcSEcCtD
Cabergoline—ADRA2A—vagina—uterine cancer	0.00159	0.00891	CbGeAlD
Cabergoline—Asthenia—Progesterone—uterine cancer	0.00159	0.00193	CcSEcCtD
Cabergoline—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00158	0.00193	CcSEcCtD
Cabergoline—Pruritus—Progesterone—uterine cancer	0.00156	0.0019	CcSEcCtD
Cabergoline—Oedema—Dactinomycin—uterine cancer	0.00156	0.0019	CcSEcCtD
Cabergoline—Abnormal vision—Epirubicin—uterine cancer	0.00155	0.00189	CcSEcCtD
Cabergoline—Mental disability—Epirubicin—uterine cancer	0.00154	0.00188	CcSEcCtD
Cabergoline—Diarrhoea—Progesterone—uterine cancer	0.00151	0.00184	CcSEcCtD
Cabergoline—Cramps of lower extremities—Doxorubicin—uterine cancer	0.00151	0.00184	CcSEcCtD
Cabergoline—HTR2A—female reproductive system—uterine cancer	0.0015	0.00837	CbGeAlD
Cabergoline—Anorexia—Dactinomycin—uterine cancer	0.00149	0.00181	CcSEcCtD
Cabergoline—Cardiac disorder—Etoposide—uterine cancer	0.00148	0.0018	CcSEcCtD
Cabergoline—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.0018	CcSEcCtD
Cabergoline—Hepatic function abnormal—Epirubicin—uterine cancer	0.00148	0.0018	CcSEcCtD
Cabergoline—Dizziness—Progesterone—uterine cancer	0.00146	0.00178	CcSEcCtD
Cabergoline—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00175	CcSEcCtD
Cabergoline—Abnormal vision—Doxorubicin—uterine cancer	0.00143	0.00175	CcSEcCtD
Cabergoline—Mental disability—Doxorubicin—uterine cancer	0.00143	0.00174	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00142	0.00173	CcSEcCtD
Cabergoline—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00173	CcSEcCtD
Cabergoline—Alopecia—Etoposide—uterine cancer	0.00141	0.00171	CcSEcCtD
Cabergoline—Vomiting—Progesterone—uterine cancer	0.00141	0.00171	CcSEcCtD
Cabergoline—Rash—Progesterone—uterine cancer	0.00139	0.0017	CcSEcCtD
Cabergoline—Dermatitis—Progesterone—uterine cancer	0.00139	0.0017	CcSEcCtD
Cabergoline—CYP3A4—female reproductive system—uterine cancer	0.00139	0.00775	CbGeAlD
Cabergoline—Headache—Progesterone—uterine cancer	0.00138	0.00169	CcSEcCtD
Cabergoline—Hot flush—Epirubicin—uterine cancer	0.00138	0.00168	CcSEcCtD
Cabergoline—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.00167	CcSEcCtD
Cabergoline—Menopausal symptoms—Epirubicin—uterine cancer	0.00137	0.00166	CcSEcCtD
Cabergoline—Hepatic function abnormal—Doxorubicin—uterine cancer	0.00137	0.00166	CcSEcCtD
Cabergoline—Decreased appetite—Dactinomycin—uterine cancer	0.00136	0.00165	CcSEcCtD
Cabergoline—HTR2A—vagina—uterine cancer	0.00135	0.00757	CbGeAlD
Cabergoline—Fatigue—Dactinomycin—uterine cancer	0.00135	0.00164	CcSEcCtD
Cabergoline—Back pain—Etoposide—uterine cancer	0.00134	0.00163	CcSEcCtD
Cabergoline—Pain—Dactinomycin—uterine cancer	0.00134	0.00163	CcSEcCtD
Cabergoline—Muscle spasms—Etoposide—uterine cancer	0.00133	0.00162	CcSEcCtD
Cabergoline—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.00161	CcSEcCtD
Cabergoline—Cardiac failure—Epirubicin—uterine cancer	0.00132	0.00161	CcSEcCtD
Cabergoline—Nausea—Progesterone—uterine cancer	0.00131	0.0016	CcSEcCtD
Cabergoline—ADRA2C—lymph node—uterine cancer	0.00129	0.00722	CbGeAlD
Cabergoline—Osteoarthritis—Epirubicin—uterine cancer	0.00129	0.00157	CcSEcCtD
Cabergoline—Feeling abnormal—Dactinomycin—uterine cancer	0.00129	0.00157	CcSEcCtD
Cabergoline—Ill-defined disorder—Etoposide—uterine cancer	0.00129	0.00157	CcSEcCtD
Cabergoline—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00128	0.00156	CcSEcCtD
Cabergoline—Hot flush—Doxorubicin—uterine cancer	0.00128	0.00155	CcSEcCtD
Cabergoline—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00155	CcSEcCtD
Cabergoline—Menopausal symptoms—Doxorubicin—uterine cancer	0.00126	0.00154	CcSEcCtD
Cabergoline—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00154	CcSEcCtD
Cabergoline—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00154	CcSEcCtD
Cabergoline—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00153	CcSEcCtD
Cabergoline—Malaise—Etoposide—uterine cancer	0.00125	0.00152	CcSEcCtD
Cabergoline—Face oedema—Epirubicin—uterine cancer	0.00124	0.00152	CcSEcCtD
Cabergoline—Vertigo—Etoposide—uterine cancer	0.00124	0.00152	CcSEcCtD
Cabergoline—Abdominal pain—Dactinomycin—uterine cancer	0.00124	0.0015	CcSEcCtD
Cabergoline—Cardiac failure—Doxorubicin—uterine cancer	0.00122	0.00149	CcSEcCtD
Cabergoline—Loss of consciousness—Etoposide—uterine cancer	0.00122	0.00148	CcSEcCtD
Cabergoline—Blood creatinine increased—Epirubicin—uterine cancer	0.00121	0.00147	CcSEcCtD
Cabergoline—Hypertension—Etoposide—uterine cancer	0.0012	0.00146	CcSEcCtD
Cabergoline—Osteoarthritis—Doxorubicin—uterine cancer	0.00119	0.00145	CcSEcCtD
Cabergoline—Liver function test abnormal—Epirubicin—uterine cancer	0.00119	0.00145	CcSEcCtD
Cabergoline—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00145	CcSEcCtD
Cabergoline—Orthostatic hypotension—Epirubicin—uterine cancer	0.00118	0.00143	CcSEcCtD
Cabergoline—Abdominal pain upper—Epirubicin—uterine cancer	0.00118	0.00143	CcSEcCtD
Cabergoline—Discomfort—Etoposide—uterine cancer	0.00117	0.00142	CcSEcCtD
Cabergoline—Face oedema—Doxorubicin—uterine cancer	0.00115	0.0014	CcSEcCtD
Cabergoline—Hypersensitivity—Dactinomycin—uterine cancer	0.00115	0.0014	CcSEcCtD
Cabergoline—Gastritis—Epirubicin—uterine cancer	0.00114	0.00139	CcSEcCtD
Cabergoline—Confusional state—Etoposide—uterine cancer	0.00114	0.00139	CcSEcCtD
Cabergoline—Asthenia—Dactinomycin—uterine cancer	0.00112	0.00137	CcSEcCtD
Cabergoline—Blood creatinine increased—Doxorubicin—uterine cancer	0.00112	0.00136	CcSEcCtD
Cabergoline—Influenza—Epirubicin—uterine cancer	0.00111	0.00136	CcSEcCtD
Cabergoline—Liver function test abnormal—Doxorubicin—uterine cancer	0.0011	0.00134	CcSEcCtD
Cabergoline—Hyperhidrosis—Etoposide—uterine cancer	0.00109	0.00133	CcSEcCtD
Cabergoline—Abdominal pain upper—Doxorubicin—uterine cancer	0.00109	0.00133	CcSEcCtD
Cabergoline—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00109	0.00133	CcSEcCtD
Cabergoline—Anorexia—Etoposide—uterine cancer	0.00108	0.00131	CcSEcCtD
Cabergoline—Bronchitis—Epirubicin—uterine cancer	0.00107	0.00131	CcSEcCtD
Cabergoline—Diarrhoea—Dactinomycin—uterine cancer	0.00107	0.0013	CcSEcCtD
Cabergoline—Hypotension—Etoposide—uterine cancer	0.00106	0.00129	CcSEcCtD
Cabergoline—Gastritis—Doxorubicin—uterine cancer	0.00106	0.00129	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Epirubicin—uterine cancer	0.00104	0.00126	CcSEcCtD
Cabergoline—Influenza—Doxorubicin—uterine cancer	0.00103	0.00126	CcSEcCtD
Cabergoline—ADRA2A—lymph node—uterine cancer	0.00103	0.00576	CbGeAlD
Cabergoline—Paraesthesia—Etoposide—uterine cancer	0.00102	0.00124	CcSEcCtD
Cabergoline—Weight increased—Epirubicin—uterine cancer	0.00101	0.00124	CcSEcCtD
Cabergoline—Weight decreased—Epirubicin—uterine cancer	0.00101	0.00123	CcSEcCtD
Cabergoline—Dyspnoea—Etoposide—uterine cancer	0.00101	0.00123	CcSEcCtD
Cabergoline—Somnolence—Etoposide—uterine cancer	0.00101	0.00122	CcSEcCtD
Cabergoline—Pneumonia—Epirubicin—uterine cancer	0.001	0.00122	CcSEcCtD
Cabergoline—Vomiting—Dactinomycin—uterine cancer	0.000993	0.00121	CcSEcCtD
Cabergoline—Bronchitis—Doxorubicin—uterine cancer	0.000992	0.00121	CcSEcCtD
Cabergoline—Rash—Dactinomycin—uterine cancer	0.000985	0.0012	CcSEcCtD
Cabergoline—Decreased appetite—Etoposide—uterine cancer	0.000983	0.0012	CcSEcCtD
Cabergoline—Fatigue—Etoposide—uterine cancer	0.000975	0.00119	CcSEcCtD
Cabergoline—Pain—Etoposide—uterine cancer	0.000967	0.00118	CcSEcCtD
Cabergoline—Constipation—Etoposide—uterine cancer	0.000967	0.00118	CcSEcCtD
Cabergoline—Urinary tract infection—Epirubicin—uterine cancer	0.000966	0.00118	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000959	0.00117	CcSEcCtD
Cabergoline—Weight increased—Doxorubicin—uterine cancer	0.000939	0.00114	CcSEcCtD
Cabergoline—Epistaxis—Epirubicin—uterine cancer	0.000937	0.00114	CcSEcCtD
Cabergoline—Weight decreased—Doxorubicin—uterine cancer	0.000933	0.00114	CcSEcCtD
Cabergoline—Feeling abnormal—Etoposide—uterine cancer	0.000932	0.00113	CcSEcCtD
Cabergoline—Nausea—Dactinomycin—uterine cancer	0.000928	0.00113	CcSEcCtD
Cabergoline—Pneumonia—Doxorubicin—uterine cancer	0.000925	0.00113	CcSEcCtD
Cabergoline—Gastrointestinal pain—Etoposide—uterine cancer	0.000925	0.00113	CcSEcCtD
Cabergoline—Rhinitis—Epirubicin—uterine cancer	0.000894	0.00109	CcSEcCtD
Cabergoline—Abdominal pain—Etoposide—uterine cancer	0.000894	0.00109	CcSEcCtD
Cabergoline—Urinary tract infection—Doxorubicin—uterine cancer	0.000894	0.00109	CcSEcCtD
Cabergoline—Oedema peripheral—Epirubicin—uterine cancer	0.000879	0.00107	CcSEcCtD
Cabergoline—Epistaxis—Doxorubicin—uterine cancer	0.000867	0.00106	CcSEcCtD
Cabergoline—Visual impairment—Epirubicin—uterine cancer	0.00086	0.00105	CcSEcCtD
Cabergoline—Hypersensitivity—Etoposide—uterine cancer	0.000833	0.00101	CcSEcCtD
Cabergoline—Cardiac disorder—Epirubicin—uterine cancer	0.000828	0.00101	CcSEcCtD
Cabergoline—Rhinitis—Doxorubicin—uterine cancer	0.000828	0.00101	CcSEcCtD
Cabergoline—Oedema peripheral—Doxorubicin—uterine cancer	0.000813	0.00099	CcSEcCtD
Cabergoline—Asthenia—Etoposide—uterine cancer	0.000811	0.000988	CcSEcCtD
Cabergoline—Pruritus—Etoposide—uterine cancer	0.0008	0.000974	CcSEcCtD
Cabergoline—Arrhythmia—Epirubicin—uterine cancer	0.000797	0.000971	CcSEcCtD
Cabergoline—Visual impairment—Doxorubicin—uterine cancer	0.000796	0.000969	CcSEcCtD
Cabergoline—Alopecia—Epirubicin—uterine cancer	0.000788	0.00096	CcSEcCtD
Cabergoline—Diarrhoea—Etoposide—uterine cancer	0.000774	0.000942	CcSEcCtD
Cabergoline—Cardiac disorder—Doxorubicin—uterine cancer	0.000766	0.000933	CcSEcCtD
Cabergoline—Flatulence—Epirubicin—uterine cancer	0.000765	0.000932	CcSEcCtD
Cabergoline—Tension—Epirubicin—uterine cancer	0.000762	0.000928	CcSEcCtD
Cabergoline—Nervousness—Epirubicin—uterine cancer	0.000754	0.000919	CcSEcCtD
Cabergoline—Back pain—Epirubicin—uterine cancer	0.000751	0.000915	CcSEcCtD
Cabergoline—Dizziness—Etoposide—uterine cancer	0.000748	0.000911	CcSEcCtD
Cabergoline—Muscle spasms—Epirubicin—uterine cancer	0.000747	0.000909	CcSEcCtD
Cabergoline—Arrhythmia—Doxorubicin—uterine cancer	0.000737	0.000898	CcSEcCtD
Cabergoline—Alopecia—Doxorubicin—uterine cancer	0.000729	0.000888	CcSEcCtD
Cabergoline—Ill-defined disorder—Epirubicin—uterine cancer	0.000721	0.000877	CcSEcCtD
Cabergoline—Vomiting—Etoposide—uterine cancer	0.000719	0.000875	CcSEcCtD
Cabergoline—Rash—Etoposide—uterine cancer	0.000713	0.000868	CcSEcCtD
Cabergoline—Dermatitis—Etoposide—uterine cancer	0.000712	0.000867	CcSEcCtD
Cabergoline—Headache—Etoposide—uterine cancer	0.000708	0.000863	CcSEcCtD
Cabergoline—Flatulence—Doxorubicin—uterine cancer	0.000708	0.000862	CcSEcCtD
Cabergoline—Tension—Doxorubicin—uterine cancer	0.000705	0.000859	CcSEcCtD
Cabergoline—Malaise—Epirubicin—uterine cancer	0.0007	0.000853	CcSEcCtD
Cabergoline—Nervousness—Doxorubicin—uterine cancer	0.000698	0.00085	CcSEcCtD
Cabergoline—Vertigo—Epirubicin—uterine cancer	0.000698	0.00085	CcSEcCtD
Cabergoline—Syncope—Epirubicin—uterine cancer	0.000696	0.000848	CcSEcCtD
Cabergoline—Back pain—Doxorubicin—uterine cancer	0.000695	0.000846	CcSEcCtD
Cabergoline—Muscle spasms—Doxorubicin—uterine cancer	0.000691	0.000841	CcSEcCtD
Cabergoline—Palpitations—Epirubicin—uterine cancer	0.000686	0.000836	CcSEcCtD
Cabergoline—Loss of consciousness—Epirubicin—uterine cancer	0.000683	0.000831	CcSEcCtD
Cabergoline—Nausea—Etoposide—uterine cancer	0.000672	0.000818	CcSEcCtD
Cabergoline—Hypertension—Epirubicin—uterine cancer	0.000671	0.000817	CcSEcCtD
Cabergoline—Ill-defined disorder—Doxorubicin—uterine cancer	0.000667	0.000812	CcSEcCtD
Cabergoline—Arthralgia—Epirubicin—uterine cancer	0.000661	0.000805	CcSEcCtD
Cabergoline—Anxiety—Epirubicin—uterine cancer	0.000659	0.000802	CcSEcCtD
Cabergoline—Discomfort—Epirubicin—uterine cancer	0.000653	0.000796	CcSEcCtD
Cabergoline—Malaise—Doxorubicin—uterine cancer	0.000648	0.000789	CcSEcCtD
Cabergoline—Dry mouth—Epirubicin—uterine cancer	0.000647	0.000787	CcSEcCtD
Cabergoline—Vertigo—Doxorubicin—uterine cancer	0.000646	0.000786	CcSEcCtD
Cabergoline—Syncope—Doxorubicin—uterine cancer	0.000644	0.000785	CcSEcCtD
Cabergoline—Confusional state—Epirubicin—uterine cancer	0.000639	0.000778	CcSEcCtD
Cabergoline—Palpitations—Doxorubicin—uterine cancer	0.000635	0.000773	CcSEcCtD
Cabergoline—Oedema—Epirubicin—uterine cancer	0.000634	0.000772	CcSEcCtD
Cabergoline—Loss of consciousness—Doxorubicin—uterine cancer	0.000632	0.000769	CcSEcCtD
Cabergoline—Shock—Epirubicin—uterine cancer	0.000624	0.000759	CcSEcCtD
Cabergoline—Hypertension—Doxorubicin—uterine cancer	0.00062	0.000756	CcSEcCtD
Cabergoline—Hyperhidrosis—Epirubicin—uterine cancer	0.000613	0.000746	CcSEcCtD
Cabergoline—Arthralgia—Doxorubicin—uterine cancer	0.000612	0.000745	CcSEcCtD
Cabergoline—Anxiety—Doxorubicin—uterine cancer	0.00061	0.000742	CcSEcCtD
Cabergoline—Discomfort—Doxorubicin—uterine cancer	0.000604	0.000736	CcSEcCtD
Cabergoline—Anorexia—Epirubicin—uterine cancer	0.000604	0.000736	CcSEcCtD
Cabergoline—Dry mouth—Doxorubicin—uterine cancer	0.000598	0.000729	CcSEcCtD
Cabergoline—Hypotension—Epirubicin—uterine cancer	0.000592	0.000721	CcSEcCtD
Cabergoline—Confusional state—Doxorubicin—uterine cancer	0.000591	0.00072	CcSEcCtD
Cabergoline—Oedema—Doxorubicin—uterine cancer	0.000586	0.000714	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000577	0.000703	CcSEcCtD
Cabergoline—Shock—Doxorubicin—uterine cancer	0.000577	0.000703	CcSEcCtD
Cabergoline—Insomnia—Epirubicin—uterine cancer	0.000573	0.000698	CcSEcCtD
Cabergoline—Paraesthesia—Epirubicin—uterine cancer	0.000569	0.000693	CcSEcCtD
Cabergoline—Hyperhidrosis—Doxorubicin—uterine cancer	0.000567	0.00069	CcSEcCtD
Cabergoline—Dyspnoea—Epirubicin—uterine cancer	0.000565	0.000688	CcSEcCtD
Cabergoline—Somnolence—Epirubicin—uterine cancer	0.000563	0.000686	CcSEcCtD
Cabergoline—Anorexia—Doxorubicin—uterine cancer	0.000559	0.000681	CcSEcCtD
Cabergoline—Dyspepsia—Epirubicin—uterine cancer	0.000558	0.000679	CcSEcCtD
Cabergoline—Decreased appetite—Epirubicin—uterine cancer	0.000551	0.000671	CcSEcCtD
Cabergoline—Hypotension—Doxorubicin—uterine cancer	0.000548	0.000667	CcSEcCtD
Cabergoline—Fatigue—Epirubicin—uterine cancer	0.000546	0.000665	CcSEcCtD
Cabergoline—Pain—Epirubicin—uterine cancer	0.000542	0.00066	CcSEcCtD
Cabergoline—Constipation—Epirubicin—uterine cancer	0.000542	0.00066	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000534	0.000651	CcSEcCtD
Cabergoline—Insomnia—Doxorubicin—uterine cancer	0.00053	0.000646	CcSEcCtD
Cabergoline—Paraesthesia—Doxorubicin—uterine cancer	0.000527	0.000641	CcSEcCtD
Cabergoline—Dyspnoea—Doxorubicin—uterine cancer	0.000523	0.000637	CcSEcCtD
Cabergoline—Feeling abnormal—Epirubicin—uterine cancer	0.000522	0.000636	CcSEcCtD
Cabergoline—Somnolence—Doxorubicin—uterine cancer	0.000521	0.000635	CcSEcCtD
Cabergoline—Gastrointestinal pain—Epirubicin—uterine cancer	0.000518	0.000631	CcSEcCtD
Cabergoline—Dyspepsia—Doxorubicin—uterine cancer	0.000516	0.000629	CcSEcCtD
Cabergoline—Decreased appetite—Doxorubicin—uterine cancer	0.00051	0.000621	CcSEcCtD
Cabergoline—Fatigue—Doxorubicin—uterine cancer	0.000506	0.000616	CcSEcCtD
Cabergoline—Pain—Doxorubicin—uterine cancer	0.000502	0.000611	CcSEcCtD
Cabergoline—Constipation—Doxorubicin—uterine cancer	0.000502	0.000611	CcSEcCtD
Cabergoline—Abdominal pain—Epirubicin—uterine cancer	0.000501	0.00061	CcSEcCtD
Cabergoline—Feeling abnormal—Doxorubicin—uterine cancer	0.000483	0.000589	CcSEcCtD
Cabergoline—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00048	0.000584	CcSEcCtD
Cabergoline—Hypersensitivity—Epirubicin—uterine cancer	0.000467	0.000569	CcSEcCtD
Cabergoline—Abdominal pain—Doxorubicin—uterine cancer	0.000464	0.000565	CcSEcCtD
Cabergoline—Asthenia—Epirubicin—uterine cancer	0.000455	0.000554	CcSEcCtD
Cabergoline—Pruritus—Epirubicin—uterine cancer	0.000448	0.000546	CcSEcCtD
Cabergoline—Diarrhoea—Epirubicin—uterine cancer	0.000434	0.000528	CcSEcCtD
Cabergoline—Hypersensitivity—Doxorubicin—uterine cancer	0.000432	0.000526	CcSEcCtD
Cabergoline—Asthenia—Doxorubicin—uterine cancer	0.000421	0.000512	CcSEcCtD
Cabergoline—Dizziness—Epirubicin—uterine cancer	0.000419	0.00051	CcSEcCtD
Cabergoline—Pruritus—Doxorubicin—uterine cancer	0.000415	0.000505	CcSEcCtD
Cabergoline—Vomiting—Epirubicin—uterine cancer	0.000403	0.000491	CcSEcCtD
Cabergoline—Diarrhoea—Doxorubicin—uterine cancer	0.000401	0.000489	CcSEcCtD
Cabergoline—Rash—Epirubicin—uterine cancer	0.0004	0.000487	CcSEcCtD
Cabergoline—Dermatitis—Epirubicin—uterine cancer	0.000399	0.000486	CcSEcCtD
Cabergoline—Headache—Epirubicin—uterine cancer	0.000397	0.000484	CcSEcCtD
Cabergoline—Dizziness—Doxorubicin—uterine cancer	0.000388	0.000472	CcSEcCtD
Cabergoline—Nausea—Epirubicin—uterine cancer	0.000376	0.000458	CcSEcCtD
Cabergoline—Vomiting—Doxorubicin—uterine cancer	0.000373	0.000454	CcSEcCtD
Cabergoline—Rash—Doxorubicin—uterine cancer	0.00037	0.00045	CcSEcCtD
Cabergoline—Dermatitis—Doxorubicin—uterine cancer	0.000369	0.00045	CcSEcCtD
Cabergoline—Headache—Doxorubicin—uterine cancer	0.000367	0.000447	CcSEcCtD
Cabergoline—Nausea—Doxorubicin—uterine cancer	0.000348	0.000424	CcSEcCtD
